175 related articles for article (PubMed ID: 16774872)
21. Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
Park SL; Carmella SG; Chen M; Patel Y; Stram DO; Haiman CA; Le Marchand L; Hecht SS
PLoS One; 2015; 10(6):e0124841. PubMed ID: 26053186
[TBL] [Abstract][Full Text] [Related]
22. The relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the US.
Mendes P; Liang Q; Frost-Pineda K; Munjal S; Walk RA; Roethig HJ
Regul Toxicol Pharmacol; 2009 Oct; 55(1):17-27. PubMed ID: 19481578
[TBL] [Abstract][Full Text] [Related]
23. Cigarettes with defective filters marketed for 40 years: what Philip Morris never told smokers.
Pauly JL; Mepani AB; Lesses JD; Cummings KM; Streck RJ
Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I51-61. PubMed ID: 11893815
[TBL] [Abstract][Full Text] [Related]
24. 2-Phenethyl Isothiocyanate, Glutathione S-transferase M1 and T1 Polymorphisms, and Detoxification of Volatile Organic Carcinogens and Toxicants in Tobacco Smoke.
Yuan JM; Murphy SE; Stepanov I; Wang R; Carmella SG; Nelson HH; Hatsukami D; Hecht SS
Cancer Prev Res (Phila); 2016 Jul; 9(7):598-606. PubMed ID: 27099270
[TBL] [Abstract][Full Text] [Related]
25. The tar reduction study: randomised trial of the effect of cigarette tar yield reduction on compensatory smoking.
Frost C; Fullerton FM; Stephen AM; Stone R; Nicolaides-Bouman A; Densem J; Wald NJ; Semmence A
Thorax; 1995 Oct; 50(10):1038-43. PubMed ID: 7491550
[TBL] [Abstract][Full Text] [Related]
26. Effect of charcoal-containing cigarette filters on gas phase volatile organic compounds in mainstream cigarette smoke.
Polzin GM; Zhang L; Hearn BA; Tavakoli AD; Vaughan C; Ding YS; Ashley DL; Watson CH
Tob Control; 2008 Sep; 17 Suppl 1():i10-6. PubMed ID: 18768454
[TBL] [Abstract][Full Text] [Related]
27. Cigarette brand-switching: effects on smoke exposure and smoking behavior.
Zacny JP; Stitzer ML
J Pharmacol Exp Ther; 1988 Aug; 246(2):619-27. PubMed ID: 3404450
[TBL] [Abstract][Full Text] [Related]
28. Relationship between cigarette format and mouth-level exposure to tar and nicotine in smokers of Russian king-size cigarettes.
Ashley M; Dixon M; Prasad K
Regul Toxicol Pharmacol; 2014 Oct; 70(1):430-7. PubMed ID: 25146962
[TBL] [Abstract][Full Text] [Related]
29. Real-World Evidence of Differences in Biomarkers of Exposure to Select Harmful and Potentially Harmful Constituents and Biomarkers of Potential Harm Between Adult E-Vapor Users and Adult Cigarette Smokers.
Oliveri D; Liang Q; Sarkar M
Nicotine Tob Res; 2020 Jun; 22(7):1114-1122. PubMed ID: 31563966
[TBL] [Abstract][Full Text] [Related]
30. Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.
Melikian AA; Djordjevic MV; Chen S; Richie J; Stellman SD
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1408-15. PubMed ID: 17627005
[TBL] [Abstract][Full Text] [Related]
31. Reported cigarette smoke values: a closer look.
Hoffmann D; Adams JD; Haley NJ
Am J Public Health; 1983 Sep; 73(9):1050-3. PubMed ID: 6881401
[TBL] [Abstract][Full Text] [Related]
32. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
[TBL] [Abstract][Full Text] [Related]
33. A survey of mouth level exposure to cigarette smoke in the United States.
Nelson PR; Chen P; Dixon M; Steichen T
Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S25-38. PubMed ID: 20937343
[TBL] [Abstract][Full Text] [Related]
34. Approaches for the design of reduced toxicant emission cigarettes.
Dittrich DJ; Fieblekorn RT; Bevan MJ; Rushforth D; Murphy JJ; Ashley M; McAdam KG; Liu C; Proctor CJ
Springerplus; 2014; 3():374. PubMed ID: 25110628
[TBL] [Abstract][Full Text] [Related]
35. Are Filter-Tipped Cigarettes Still Less Harmful than Non-Filter Cigarettes?--A Laser Spectrometric Particulate Matter Analysis from the Non-Smokers Point of View.
Schulz M; Gerber A; Groneberg DA
Int J Environ Res Public Health; 2016 Apr; 13(4):429. PubMed ID: 27092519
[TBL] [Abstract][Full Text] [Related]
36. Electronic cigarette-generated aldehydes: The contribution of e-liquid components to their formation and the use of urinary aldehyde metabolites as biomarkers of exposure.
Conklin DJ; Ogunwale MA; Chen Y; Theis WS; Nantz MH; Fu XA; Chen LC; Riggs DW; Lorkiewicz P; Bhatnagar A; Srivastava S
Aerosol Sci Technol; 2018; 52(11):1219-1232. PubMed ID: 31456604
[TBL] [Abstract][Full Text] [Related]
37. Semi-volatiles in mainstream smoke delivery from select charcoal-filtered cigarette brand variants.
Hearn BA; Ding YS; Vaughan C; Zhang L; Polzin G; Caudill SP; Watson CH; Ashley DL
Tob Control; 2010 Jun; 19(3):223-30. PubMed ID: 20501495
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of biomarkers of exposure in adult cigarette smokers using Marlboro snus.
Sarkar M; Liu J; Koval T; Wang J; Feng S; Serafin R; Jin Y; Xie Y; Newland K; Roethig HJ
Nicotine Tob Res; 2010 Feb; 12(2):105-16. PubMed ID: 20026503
[TBL] [Abstract][Full Text] [Related]
39. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey.
Jarvis MJ; Boreham R; Primatesta P; Feyerabend C; Bryant A
J Natl Cancer Inst; 2001 Jan; 93(2):134-8. PubMed ID: 11208883
[TBL] [Abstract][Full Text] [Related]
40. A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites.
St Charles FK; Krautter GR; Dixon M; Mariner DC
Psychopharmacology (Berl); 2006 Dec; 189(3):345-54. PubMed ID: 17028908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]